Literature DB >> 33503805

Estrogen Receptor Signaling Pathways Involved in Invasion and Colony Formation of Androgen-Independent Prostate Cancer Cells PC-3.

Ana Paola G Lombardi1, Renan P Cavalheiro2, Catarina S Porto1, Carolina M Vicente1.   

Abstract

Castration-resistant prostate cancer (CRPC) is an advanced and androgen-independent form of prostate cancer. Recent studies of rapid actions mediated by estrogen in the prostate and its relationship with CRPC are emerging. We have previously shown that estrogen receptor (ER) promotes migration and invasion of the androgen-independent prostate cancer cells PC-3, but the signaling pathways involved in these events remain to be elucidated. Therefore, this study aimed to analyze the role of ERα and ERβ in the activation of SRC, and the involvement of SRC and PI3K/AKT on invasion and colony formation of the PC-3 cells. Our results showed that the activation of ERα (using ERα-selective agonist PPT) and ERβ (using ERβ-selective agonist DPN) increased phosphorylation of SRC in PC-3 cells. In the presence of the selective inhibitor for SRC-family kinases PP2, the effects of DPN and PPT on transmigration and soft agar colony formation assays were decreased. Furthermore, SRC is involved in the expression of the non-phosphorylated β-catenin. Finally, using PI3K specific inhibitor Wortmannin and AKT inhibitor MK2206, we showed that PI3K/AKT are also required for invasion and colony formation of PC-3 cells simulated by ER. This study provides novel insights into molecular mechanisms of ER in PC-3 cells by demonstrating that ER, located outside the cell nucleus, activates rapid responses molecules, including SRC and PI3K/AKT, which enhance the tumorigenic potential of prostate cancer cells, increasing cell proliferation, migration, invasion, and tumor formation.

Entities:  

Keywords:  PC-3 cells; PI3K/AKT; SRC; estrogen receptor; β-catenin

Mesh:

Substances:

Year:  2021        PMID: 33503805      PMCID: PMC7865506          DOI: 10.3390/ijms22031153

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  45 in total

Review 1.  Integrin-regulated FAK-Src signaling in normal and cancer cells.

Authors:  Satyajit K Mitra; David D Schlaepfer
Journal:  Curr Opin Cell Biol       Date:  2006-08-17       Impact factor: 8.382

2.  Src couples estrogen receptor to the anticipatory unfolded protein response and regulates cancer cell fate under stress.

Authors:  Liqun Yu; Lawrence Wang; Ji Eun Kim; Chengjian Mao; David J Shapiro
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-06-02       Impact factor: 4.739

Review 3.  Estrogen receptor signaling mechanisms.

Authors:  Nathalie Fuentes; Patricia Silveyra
Journal:  Adv Protein Chem Struct Biol       Date:  2019-02-04       Impact factor: 3.507

Review 4.  Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling.

Authors:  Julian Heuberger; Walter Birchmeier
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

5.  PTEN loss-mediated Akt activation increases the properties of cancer stem-like cell populations in prostate cancer.

Authors:  Ran-Ju Kim; Eunjin Bae; Young Kwon Hong; Jae Yup Hong; Nam Keun Kim; Hee Jung Ahn; Jong Jin Oh; Dong Soo Park
Journal:  Oncology       Date:  2014-08-15       Impact factor: 2.935

6.  Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity.

Authors:  Annett Hahn-Windgassen; Veronique Nogueira; Chia-Chen Chen; Jennifer E Skeen; Nahum Sonenberg; Nissim Hay
Journal:  J Biol Chem       Date:  2005-07-15       Impact factor: 5.157

Review 7.  Androgen receptor in prostate cancer.

Authors:  Cynthia A Heinlein; Chawnshang Chang
Journal:  Endocr Rev       Date:  2004-04       Impact factor: 19.871

8.  SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells.

Authors:  Carolina M Vicente; Marcelo A Lima; Helena B Nader; Leny Toma
Journal:  J Exp Clin Cancer Res       Date:  2015-03-14

9.  HCRP-1 regulates cell migration, invasion and angiogenesis via Src/ FAK signaling in human prostate cancer.

Authors:  Feifei Chen; Jianqiang Wu; Jingwei Teng; Wang Li; Junnian Zheng; Jin Bai
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 6.580

Review 10.  Development and prevalence of castration-resistant prostate cancer subtypes.

Authors:  Jordan E Vellky; William A Ricke
Journal:  Neoplasia       Date:  2020-09-25       Impact factor: 5.715

View more
  2 in total

Review 1.  Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment.

Authors:  Dali Tong
Journal:  J Immunother Cancer       Date:  2022-04       Impact factor: 13.751

Review 2.  Choosing Kinase Inhibitors for Androgen Deprivation Therapy-Resistant Prostate Cancer.

Authors:  Shangwei Zhong; Shoujiao Peng; Zihua Chen; Zhikang Chen; Jun-Li Luo
Journal:  Pharmaceutics       Date:  2022-02-24       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.